# V2X, Inc.: financial statements, quarterly

VVX · NYSE · CIK 1601548 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vvx.md) · [Financials](/companies/vvx/financials.md) · [Filings](/companies/vvx/filings.md) · [Insiders](/companies/vvx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vvx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,002](/filings/0001601548-24-000021.md) | [1,040 d](/filings/0001601548-26-000015.md) | [1,011](/filings/0001601548-25-000025.md) | [1,072](/filings/0001601548-25-000048.md) | [1,082](/filings/0001601548-25-000066.md) | [1,158 d](/filings/0001601548-26-000015.md) | [1,016](/filings/0001601548-26-000025.md) | [1,078](/filings/0001601548-26-000038.md) | [1,167](/filings/0001601548-25-000066.md) | [1,219 d](/filings/0001601548-26-000015.md) | [1,254](/filings/0001601548-26-000025.md) | [1,257](/filings/0001601548-26-000038.md) |
| Cost of revenue | $m | [931](/filings/0001601548-24-000021.md) | [942 d](/filings/0001601548-26-000015.md) | [940](/filings/0001601548-25-000025.md) | [998](/filings/0001601548-25-000048.md) | [990](/filings/0001601548-25-000066.md) | [1,050 d](/filings/0001601548-26-000015.md) | [938](/filings/0001601548-26-000025.md) | [983](/filings/0001601548-26-000038.md) | [1,073](/filings/0001601548-25-000066.md) | [1,114 d](/filings/0001601548-26-000015.md) | [1,148](/filings/0001601548-26-000025.md) | [1,147](/filings/0001601548-26-000038.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [49.6](/filings/0001601548-24-000021.md) | [59.4 d](/filings/0001601548-26-000015.md) | [39.9](/filings/0001601548-25-000025.md) | [46.4](/filings/0001601548-25-000048.md) | [41.5](/filings/0001601548-25-000066.md) | [55.9 d](/filings/0001601548-26-000015.md) | [43.8](/filings/0001601548-26-000025.md) | [42.8](/filings/0001601548-26-000038.md) | [38.8](/filings/0001601548-25-000066.md) | [53.7 d](/filings/0001601548-26-000015.md) | [61.7](/filings/0001601548-26-000025.md) | [55.7](/filings/0001601548-26-000038.md) |
| Operating income | $m | [21.0](/filings/0001601548-24-000021.md) | [38.5 d](/filings/0001601548-26-000015.md) | [30.3](/filings/0001601548-25-000025.md) | [27.4](/filings/0001601548-25-000048.md) | [49.9](/filings/0001601548-25-000066.md) | [51.6 d](/filings/0001601548-26-000015.md) | [34.3](/filings/0001601548-26-000025.md) | [52.9](/filings/0001601548-26-000038.md) | [55.7](/filings/0001601548-25-000066.md) | [51.4 d](/filings/0001601548-26-000015.md) | [44.1](/filings/0001601548-26-000025.md) | [53.8](/filings/0001601548-26-000038.md) |
| Income tax | $m | [(4.8)](/filings/0001601548-24-000021.md) | [8.4 d](/filings/0001601548-26-000015.md) | [(0.0)](/filings/0001601548-25-000025.md) | [(1.6)](/filings/0001601548-25-000048.md) | [4.5](/filings/0001601548-25-000066.md) | [1.3 d](/filings/0001601548-26-000015.md) | [2.0](/filings/0001601548-26-000025.md) | [7.1](/filings/0001601548-26-000038.md) | [8.1](/filings/0001601548-25-000066.md) | [5.9 d](/filings/0001601548-26-000015.md) | [4.6](/filings/0001601548-26-000025.md) | [7.7](/filings/0001601548-26-000038.md) |
| Net income | $m | [(6.4)](/filings/0001601548-24-000021.md) | [(0.5) d](/filings/0001601548-26-000015.md) | [1.1](/filings/0001601548-25-000066.md) | [(6.5)](/filings/0001601548-25-000066.md) | [15.1](/filings/0001601548-25-000066.md) | [25.0 d](/filings/0001601548-26-000015.md) | [8.1](/filings/0001601548-26-000038.md) | [22.4](/filings/0001601548-26-000038.md) | [24.6](/filings/0001601548-25-000066.md) | [22.8 d](/filings/0001601548-26-000015.md) | [18.9](/filings/0001601548-26-000038.md) | [25.5](/filings/0001601548-26-000038.md) |
| Diluted EPS | $ per share | [(0.21)](/filings/0001601548-24-000021.md) | not reported | [0.04](/filings/0001601548-25-000025.md) | [(0.21)](/filings/0001601548-25-000048.md) | [0.47](/filings/0001601548-25-000066.md) | not reported | [0.25](/filings/0001601548-26-000025.md) | [0.70](/filings/0001601548-26-000038.md) | [0.77](/filings/0001601548-25-000066.md) | not reported | [0.60](/filings/0001601548-26-000025.md) | [0.81](/filings/0001601548-26-000038.md) |
| Basic EPS | $ per share | [(0.21)](/filings/0001601548-24-000021.md) | not reported | [0.04](/filings/0001601548-25-000025.md) | [(0.21)](/filings/0001601548-25-000048.md) | [0.48](/filings/0001601548-25-000066.md) | not reported | [0.26](/filings/0001601548-26-000025.md) | [0.71](/filings/0001601548-26-000038.md) | [0.78](/filings/0001601548-25-000066.md) | not reported | [0.61](/filings/0001601548-26-000025.md) | [0.82](/filings/0001601548-26-000038.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [894](/filings/0001601548-23-000041.md) | [875](/filings/0001601548-25-000009.md) | [954](/filings/0001601548-24-000009.md) | [977](/filings/0001601548-24-000017.md) | [982](/filings/0001601548-24-000021.md) | [1,102](/filings/0001601548-26-000015.md) | [1,003](/filings/0001601548-25-000025.md) | [1,067](/filings/0001601548-25-000048.md) | [1,099](/filings/0001601548-25-000066.md) | [1,226](/filings/0001601548-26-000038.md) | [1,169](/filings/0001601548-26-000025.md) | [1,205](/filings/0001601548-26-000038.md) |
| Total assets | $m | [3,126](/filings/0001601548-23-000041.md) | [3,082](/filings/0001601548-25-000009.md) | [3,140](/filings/0001601548-24-000009.md) | [3,151](/filings/0001601548-24-000017.md) | [3,126](/filings/0001601548-24-000021.md) | [3,229](/filings/0001601548-26-000015.md) | [3,103](/filings/0001601548-25-000025.md) | [3,146](/filings/0001601548-25-000048.md) | [3,178](/filings/0001601548-25-000066.md) | [3,272](/filings/0001601548-26-000038.md) | [3,189](/filings/0001601548-26-000025.md) | [3,198](/filings/0001601548-26-000038.md) |
| Current liabilities | $m | [830](/filings/0001601548-23-000041.md) | [840](/filings/0001601548-25-000009.md) | [853](/filings/0001601548-24-000009.md) | [888](/filings/0001601548-24-000017.md) | [906](/filings/0001601548-24-000021.md) | [996](/filings/0001601548-26-000015.md) | [867](/filings/0001601548-25-000025.md) | [887](/filings/0001601548-25-000048.md) | [914](/filings/0001601548-25-000066.md) | [1,007](/filings/0001601548-26-000038.md) | [933](/filings/0001601548-26-000025.md) | [914](/filings/0001601548-26-000038.md) |
| Total liabilities | $m | [2,137](/filings/0001601548-23-000041.md) | [2,091](/filings/0001601548-25-000009.md) | [2,146](/filings/0001601548-24-000009.md) | [2,159](/filings/0001601548-24-000017.md) | [2,124](/filings/0001601548-24-000021.md) | [2,203](/filings/0001601548-26-000015.md) | [2,068](/filings/0001601548-25-000025.md) | [2,080](/filings/0001601548-25-000048.md) | [2,098](/filings/0001601548-25-000066.md) | [2,188](/filings/0001601548-26-000038.md) | [2,086](/filings/0001601548-26-000025.md) | [2,064](/filings/0001601548-26-000038.md) |
| Long-term debt | $m | [1,153](/filings/0001601548-23-000041.md) | [1,100](/filings/0001601548-25-000009.md) | [1,154](/filings/0001601548-24-000009.md) | [1,142](/filings/0001601548-24-000017.md) | [1,097](/filings/0001601548-24-000021.md) | [1,087](/filings/0001601548-26-000015.md) | [1,090](/filings/0001601548-25-000025.md) | [1,092](/filings/0001601548-25-000048.md) | [1,089](/filings/0001601548-25-000066.md) | [1,083](/filings/0001601548-26-000038.md) | [1,061](/filings/0001601548-26-000025.md) | [1,048](/filings/0001601548-26-000038.md) |
| Current portion of debt | $m | [15.5](/filings/0001601548-23-000041.md) | [15.4](/filings/0001601548-25-000009.md) | [15.4](/filings/0001601548-24-000009.md) | [16.9](/filings/0001601548-24-000017.md) | [16.9](/filings/0001601548-24-000021.md) | [20.0](/filings/0001601548-26-000015.md) | [19.9](/filings/0001601548-25-000025.md) | [14.9](/filings/0001601548-25-000048.md) | [14.9](/filings/0001601548-25-000066.md) | [14.9](/filings/0001601548-26-000038.md) | [14.9](/filings/0001601548-26-000025.md) | [16.1](/filings/0001601548-26-000038.md) |
| Shareholders' equity | $m | [989](/filings/0001601548-24-000021.md) | [991](/filings/0001601548-26-000015.md) | [994](/filings/0001601548-25-000066.md) | [992](/filings/0001601548-25-000066.md) | [1,003](/filings/0001601548-25-000066.md) | [1,026](/filings/0001601548-26-000038.md) | [1,036](/filings/0001601548-26-000038.md) | [1,066](/filings/0001601548-26-000038.md) | [1,080](/filings/0001601548-25-000066.md) | [1,085](/filings/0001601548-26-000038.md) | [1,104](/filings/0001601548-26-000038.md) | [1,134](/filings/0001601548-26-000038.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [57.0 d](/filings/0001601548-24-000021.md) | [52.8 d](/filings/0001601548-26-000015.md) | [(57.2)](/filings/0001601548-25-000025.md) | [25.7 d](/filings/0001601548-25-000048.md) | [62.7 d](/filings/0001601548-25-000066.md) | [223 d](/filings/0001601548-26-000015.md) | [(95.5)](/filings/0001601548-26-000025.md) | [28.5 d](/filings/0001601548-26-000038.md) | [39.4 d](/filings/0001601548-25-000066.md) | [209 d](/filings/0001601548-26-000015.md) | [(130)](/filings/0001601548-26-000025.md) | [21.6 d](/filings/0001601548-26-000038.md) |
| Capital expenditure | $m | [5.0 d](/filings/0001601548-24-000021.md) | [8.5 d](/filings/0001601548-26-000015.md) | [7.8](/filings/0001601548-25-000025.md) | [0.7 d](/filings/0001601548-25-000048.md) | [2.2 d](/filings/0001601548-25-000066.md) | [1.1 d](/filings/0001601548-26-000015.md) | [2.7](/filings/0001601548-26-000025.md) | [2.5 d](/filings/0001601548-26-000038.md) | [4.5 d](/filings/0001601548-25-000066.md) | [2.3 d](/filings/0001601548-26-000015.md) | [2.3](/filings/0001601548-26-000025.md) | [1.1 d](/filings/0001601548-26-000038.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001601548-26-000015.md) | not reported | not reported | not reported | [20.0 d](/filings/0001601548-26-000015.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [29.8](/filings/0001601548-23-000041.md) | [30.9](/filings/0001601548-24-000009.md) | [31.6](/filings/0001601548-24-000017.md) | [31.2](/filings/0001601548-24-000021.md) | [31.8](/filings/0001601548-25-000025.md) | [31.5](/filings/0001601548-25-000048.md) | [32.0](/filings/0001601548-25-000066.md) | [32.0](/filings/0001601548-26-000025.md) | [31.9](/filings/0001601548-26-000038.md) | [31.9](/filings/0001601548-25-000066.md) | [31.5](/filings/0001601548-26-000025.md) | [31.5](/filings/0001601548-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 31,345,358 at 2026-07-28, from the cover of the [10-Q filed 2026-08-03](/filings/0001601548-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.